Business context and reporting period
The filing is Zaxis International Inc.’s unaudited Form 10-Q for the quarter and six months ended June 30, 2014. The request metadata names Quantum X Labs Inc.; that company name does not match the registrant identified in the filing. Zaxis reports that it has no current operations and is a shell company seeking a business combination. It had not identified a target business or industry.
Financial results and position
| Metric | Three months ended June 30 | Six months ended June 30 |
|---|---|---|
| Revenue, 2014 / 2013 | $0 / $0 | $0 / $0 |
| General and administrative expense, 2014 / 2013 | $6,500 / $9,750 | $14,250 / $21,700 |
| Interest expense, 2014 / 2013 | $307 / $2,550 | $2,678 / $5,100 |
| Net loss, 2014 / 2013 | $6,807 / $12,300 | $16,928 / $26,800 |
General and administrative expense declined 33% for the quarter and 34% for the six-month period, which management attributed mainly to lower officer compensation and office expenses. Lower interest expense reflected reduced rates on convertible notes. With no revenue, operating or profit margins are not meaningful.
For the six months, operating cash use was $7,750, offset by $7,750 of financing advances; ending cash was $0. In the prior-year period, operating cash use was $4,450, matched by $4,450 of financing. At June 30, 2014, the balance sheet showed no assets, current liabilities of $170,707, long-term convertible notes of $125,000, total liabilities of $295,707, and a stockholders’ deficit of $295,707. Accumulated deficit was $417,122. Common shares outstanding were 1,695,126 at June 30 and August 8, 2014.
Material changes, debt and liquidity
In March 2014, the principal shareholder assigned notes and accrued advances to unaffiliated parties. The filing reports 15 convertible notes totaling $125,000, bearing 1% interest and generally due July 1, 2015; conversion prices include $0.01 and $0.005 per share. The company also reported a $40,000 noncash transfer of advances from a related party to an unrelated party and an $85,000 transfer of convertible notes. The conversion terms could significantly dilute existing shareholders.
The filing’s MD&A states current liabilities were $129,479, but describes that amount as including accounts payable of $6,500 and accrued interest of $34,728. The balance sheet reports current liabilities of $170,707, which is the sum of those amounts and $129,479 of advances. This is an apparent inconsistency requiring verification.
Outlook, risks and controls
Management intends to use limited resources to pursue a business combination and may seek debt or equity financing, but reports no financing agreements and cannot assure that funds will be available on acceptable terms. Management warns that a transaction may require issuing substantial restricted shares, diluting existing holders and potentially changing control. A single combination may leave the company dependent on one business. The filing states that losses, negative operating cash flows and no revenue raise substantial doubt about the company’s ability to continue as a going concern. No legal proceedings were reported.
Management concluded disclosure controls and procedures were ineffective as of June 30, 2014 because of insufficient segregation of duties. It reported no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the intended issuer: the filing is for Zaxis International Inc., not Quantum X Labs Inc.
- Reconcile the $129,479 current-liability figure in MD&A with the balance-sheet total of $170,707.
- Verify the outstanding debt, accrued interest, maturity dates, conversion prices and potential dilution from the 15 notes.
- Assess the company’s going-concern uncertainty, zero cash and ability to fund operations or complete a business combination.
- Review the ineffective disclosure controls and the risks of a transaction involving an unidentified target.